An SIO membership provides you with numerous personal and professional benefits, resources for growth and...
source: SIO
The Society of Interventional Oncology submitted updates to the NCCN renal guidelines. Submitted by Ronald S. Arellano MD, Professor of Radiology, Harvard University; Thomas D. Atwell MD, Professor of Radiology, Mayo Clinic; and S. William Stavropoulos MD, Professor of...
source: SIO
Michael R. Charlton, MD, MBBS, professor of medicine, director of the Center for Liver Diseases, and codirector of the Transplant Institute at the University of Chicago Medicine, discusses the impact of the LEGACY trial investigating...
source: Targeted Oncology
Using a cohort of surgically treated hepatocellular carcinomas (HCCs), it was inquired if transarterial chemoembolisation (TACE) holds the potential to modulate programmed death‐1 (PD‐1)...
source: MD Linx
Researchers conducted a comparative effectiveness research study with the aim to determine the treatment modality—liver transplant or portal vein embolization followed by liver...
source: MD Linx
This study set out to evaluate the safety and technical efficacy of a customized blunt-tip microwave ablation (MWA) electrode for CT-guided ablation of pulmonary ground-glass opacity nodules (GGOs).
source: DocWireNews
The present study was performed to explore the feasibility, safety, and effectiveness of ultrasound-guided transperineal laser ablation (TPLA) as a new minimally invasive surgical...
source: MD Linx
SIO Board Member Dr. Michael C. Soulen was awarded the SIR Gold Medal. The SIR Gold Medal is the highest honor bestowed by the Society of Interventional Radiology for excellence and liferime achievement in interventional radiology to individuals who have rendered exceptional...
source: SIO
As a reminder, from now through Tuesday, 6 April 2021, registrants will have access to all virtual platform content. Don't miss out on this opportunity to explore the Exhibit Hall, rewatch recordings, and claim your CME credit by 6 April.
REVIEW RECORDINGS NOW
source: SIO
SIO President, Matthew Callstrom, MD, PhD along with former president Stephen Solomon, MD and David Breen, MD interviewed with InterventionalNews in an article outlining the benefits of thermal ablation on patient outcomes for the treatment of various tumors. Click here...
source: InterventionalNews
We retrospectively examined the venous thromboembolism (VTE) events diagnosed in the Prophylaxis of High-Risk Ambulatory Cancer Patients Study (PHACS), a multi-center randomized trial, to assess the value...
source: DocWireNews
This study sought to determine the diagnostic efficacy of gadolinium-based contrast agents for the detection of recurrent soft-tissue sarcoma compared with non-contrast-enhanced conventional MRI sequences.
source: PubMed
More than 10 hereditary renal tumor syndromes (HRTSs) and related germline mutations have been reported with HRTS-associated renal and extrarenal manifestations with benign and malignant tumors. Radiologists play an important role in...
source: DocWireNews
For persons at high risk for HCC, current guidelines recommend initial screening and follow-up surveillance imaging. The low cost and availability of US typically make this modality the frontline screening method, but US fails to detect...
source: RSNA
Treatment response following transarterial chemoembolization (TACE) is frequently evaluated with Liver Imaging Reporting and Data System Treatment Response (LR-TR) algorithm,...
source: PubMed
